Efficacy of ozone adjuvant therapy in COVID-19 patients: A meta-analysis study

被引:9
|
作者
Jafari-Oori, Mehdi [1 ]
Vahedian-azimi, Amir [2 ]
Ghorbanzadeh, Kobra [3 ]
Sepahvand, Elham [4 ]
Dehi, Manijeh [5 ]
Ebadi, Abbas [6 ]
Izadi, Mortaza [7 ]
机构
[1] Baqiyatallah Univ Med Sci, Fac Nursing, Atherosclerosis Res Ctr, Tehran, Iran
[2] Baqiyatallah Univ Med Sci, Nursing Fac, Trauma Res Ctr, Tehran, Iran
[3] Khalkhal Univ Med Sci, Dept Nursing, Khalkhal, Iran
[4] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Poledokhtar Sch Nursing, Lorestan, Iran
[5] Maragheh Univ Med Sci, Dept Nursing, Maragheh, Iran
[6] Baqiyatallah Univ Med Sci, Life Style Inst, Fac Nursing, Behav Sci Res Ctr, Tehran, Iran
[7] Baqiyatallah Univ Med Sci, Life Style Inst, Hlth Res Ctr, Tehran, Iran
关键词
COVID-19; ozone therapy; standard treatment; systematic review; meta-analysis; OXYGEN-OZONE; HETEROGENEITY; INFECTION;
D O I
10.3389/fmed.2022.1037749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionUsing ozone therapy to manage COVID-19 patients has been accompanied by conflicting results in prior studies. Therefore, we aimed to widely assess the effects of ozone as adjuvant therapy in COVID-19 patients. MethodsPubMed, Scopus, Web of Science, Cochrane, ProQuest, Springer, and Sage journals were searched systematically until April 2022. Mortality rate, ICU admission, hospital-length stay, negative PCR, pulmonary, renal, and hepatic functions, as well as inflammatory and blood systems were pooled to compare the efficacy of ozone as adjacent therapy (OZ) and standard treatment (ST). Analyses were run with the random/fixed models, sub-group analysis, funnel plot, and sensitivity analysis using comprehensive meta-analysis (CMA) software version 2.0. ResultsThe results of four randomized clinical trials (RCTs) and four case-control studies with a total of 371 COVID-19 positive patients were analyzed. The OZ group patients had a shorter length of hospital stay (P > 0.05), lower ICU admissions (P > 0.05), and lower mortality rates (P < 0.05) than the ST group cases. After treatment, 41% more COVID-19 patients had negative PCR tests than the ST group (P < 0.05). Serum creatinine and urea levels were not modified in either group (P > 0.05). Moreover, except for albumin serum levels, which decreased significantly in the OZ group, serum bilirubin, ALT, and AST were not modified in either group (P > 0.05). Both arms did not show a decrease in C-reactive protein blood levels (P > 0.05), but the OZ group showed a significant modification in LDH serum levels (P < 0.05). Unlike the d-dimer and WBC serum levels (P > 0.05), platelet levels were increased in the OZ group (P < 0.05). No negative side effects were demonstrated in either group. ConclusionOzone therapy was effective significantly on PCR test and LDH serum levels, as well as mortality based on overall estimation. Concerning the length of hospital stay and ICU admissions, although the results were insignificant, their effect sizes were notable clinically. More RCT studies are needed to show the efficacy of ozone therapy on other studied variables.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Ozone as an adjuvant therapy for COVID-19: A systematic review and meta-analysis
    Budi, David Setyo
    Rofananda, Ihsan Fahmi
    Pratama, Nando Reza
    Sutanto, Henry
    Hariftyani, Arisvia Sukma
    Desita, Saskia Ratna
    Rahmasari, Aulia Zinedinita
    Asmarawati, Tri Pudy
    Waskito, Langgeng Agung
    Wungu, Citrawati Dyah Kencono
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
  • [2] Safety and efficacy of melatonin as an adjuvant therapy in COVID-19 patients: Systematic review and meta-analysis
    Taha, Amira Mohamed
    Saed, Sara Adel Abdelkader
    Moawad, Mostafa Hossam-Eldin
    Moawad, Wesam Abd El-Tawab
    Al-hejazi, Tala
    Mousa, Yosra
    Sharma, Ramaswamy
    Reiter, Russel J.
    ADVANCES IN MEDICAL SCIENCES, 2023, 68 (02): : 341 - 352
  • [3] Ginseng adjuvant therapy on COVID-19 A protocol for systematic review and meta-analysis
    Shi, Hang
    Xia, Yawen
    Gu, Renjun
    Yu, Shuang
    MEDICINE, 2021, 100 (43) : E27586
  • [4] Benefits of ozone on mortality in patients with COVID-19: A systematic review and meta-analysis
    Shang, Wenli
    Wang, Yan
    Wang, Guizuo
    Han, Dong
    COMPLEMENTARY THERAPIES IN MEDICINE, 2023, 72
  • [5] Efficacy and Safety of Blood Derivative Therapy for Patients with COVID-19: A Systematic Review and Meta-Analysis
    Fei, Zhangcheng
    Chen, Zhongsheng
    Du, Xi
    Cao, Haijun
    Li, Changqing
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2022, 49 (06) : 388 - 400
  • [6] Efficacy and Safety of Convalescence Plasma Therapy in COVID-19 Patients: A Systematic Review and Meta-Analysis
    Dai, Rongjuan
    Hu, Minjie
    Tang, Haibo
    Peng, Zhongtian
    Yan, Cai
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [7] Efficacy and safety outcomes with remdesivir in COVID-19 patients: A meta-analysis
    Tejas Kamleshbhai Patel
    Parvati B Patel
    Manish Barvaliya
    Vijayalaxmi
    Hira Lal Bhalla
    World Journal of Meta-Analysis, 2021, 9 (01) : 74 - 87
  • [8] Lack of efficacy for sotrovimab use in patients with COVID-19: A meta-analysis
    Ao, Guangyu
    Li, Toni
    Wang, Yushu
    Tran, Carolyn
    Qi, Xin
    JOURNAL OF INFECTION, 2022, 85 (01) : E10 - E12
  • [9] Efficacy and safety of remdesivir in COVID-19 patients: An overview of meta-analysis
    Rajan, Asha K.
    Kaur, Harsimran
    Hafis, A.
    Rashid, Muhammed
    Poojari, Pooja G. Gopal
    Shanbhag, Vishal
    Chaudhuri, Souvik
    Thunga, Girish P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 217 - 218
  • [10] Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis
    Vegivinti, Charan T. R.
    Pederson, John M.
    Saravu, Kavitha
    Gupta, Nitin
    Evanson, Kirk W.
    Kamrowski, Shelby
    Schmidt, Megan
    Barrett, Averi
    Trent, Hannah
    Dibas, Mahmoud
    Reierson, Natalie L.
    Mikoff, Nick
    Pisipati, Sailaja
    Joseph, Betsy A.
    Selvan, Pragadeesh T.
    Dmytriw, Adam A.
    Pulakurthi, Yashwitha S.
    Keesari, Praneeth R.
    Sriram, Varsha
    Chittajallu, Spandana
    Brinjikji, Waleed
    Katamreddy, Rewanth R.
    Chibbar, Richa
    Davis, Amber R.
    Malpe, Manashree
    Mishra, Hemant K.
    Kallmes, Kevin M.
    Hassan, Ameer E.
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (03) : 470 - 482